Sanofi Pasteur Ltd
$415,000,000.00 CAD
- Program
- SIF Stream 3 - Attraction
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- March 26, 2021 – June 30, 2039
- Reference
- ic:033-2020-2021-Q4-815915
Published purpose
The project will support the development of a new bulk vaccine manufacturing facility and install state of the art drug product formulation, filling, inspection and packaging (FFIP) capabilities in an existing facility in Toronto, Ontario. The project’s work phase is scheduled to end on March 31, 2027.
In plain English AI-generated
This funding supports Sanofi Pasteur in building a new bulk vaccine manufacturing facility and adding drug product formulation, filling, inspection, and packaging capabilities at an existing site in Toronto, Ontario.
Category: Health Primarily funds activity in Canada
Based on the published description. See how AI categorization works — the linked official record is authoritative.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.